Login

PledPharma CEO, Nicklas Westerholm 00:00:00

Share On Facebook Share On Twitter

PledPharma / Pareto Securities’ 11th Annual Healthcare Conference

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Unveiling the Evolution: Yoni Assia on eToro's Path to Democratizing Finance | Yoni Assia , CEO, eToro.
00:10:00
Advancements in Genetic Testing and Tumor Profiling for Uveal Melanoma Management |Derek J Maetzold, CEO, Castle Biosciences Inc.
00:10:00
Budimex Mobility's Market Development: Insights from Ksawery Lesiecki, Market Development Manager
00:10:00
Joining O’Melveny: Achieve More | Allen Burton - Partner, O'Melveny & Myers LLP
00:10:00
Building a Global VC firm & Learnings From Indian Founders|Vinny Pujji,Managing Partner,Left Lane Capital
00:10:00
Insights from D.P. Singh on Mutual Funds and Investment Strategies | DP Singh , CBO , SBI Mutual Fund.
00:10:00
THE WAY EDGE LEARNING GUIDES COMPLEX PART ASSEMBLY AND AUGMENTED REALITY | Robert J. Willett, CEO, Cognex CorpCGZF:FRA
00:10:00
"John Richards, of Brickability Group PLC (AIM: BRCK), celebrates their inaugural acquisition in the renewable energy products sector, valued at £5.5 million."|John Richards is currently the Non-Executive Chairman at Brickability Group Plc
00:10:00
Carmen Pérez Baguena on Cobas AM's Retail Sector Investment Strategy
00:10:00
Malvern Panalytical's Ambitious Path to Net Zero: An Interview with Tonic Reinders
00:10:00
Essential Financial Tips: Building an Emergency Fund, Budgeting, and Retirement Planning
00:10:00
Data Respons Hackathon 2023 | Kenneth Ragnvaldsen, CEO, Data Respons ASADAT:OSL

© 2026 Nehu